Answers are grounded in this paper and cite their sources.
The Wnt/β-catenin signaling pathway is one of the most frequently dysregulated pathways in human malignancies and plays an important role in tumor proliferation, metastasis, stemness, and therapy resistance, particularly in triple-negative breast cancer (TNBC). Persistent activation of β-catenin signaling contributes to aggressive tumor phenotypes and poor clinical outcomes, making β-catenin an attractive therapeutic target. However, direct inhibition of β-catenin remains challenging because the protein lacks catalytic domains and possesses broad protein–protein interaction interfaces that are difficult to target using conventional small molecules. Recent studies have identified cryptic allosteric pockets within β-catenin that may serve as alternative sites for therapeutic modulation. In the present study, α-mangostin, a xanthone compound isolated from mangosteen rind (Garcinia mangostana), was structurally modified through benzoylation to generate derivatives with improved binding potential toward the allosteric region of β-catenin. A total of eighty-one benzoylated α-mangostin derivatives were designed and evaluated using an integrated computational strategy consisting of allosteric site prediction, pharmacophore modeling, molecular docking, molecular dynamics simulations, and binding free-energy analysis. Molecular docking at the PASSer-predicted allosteric pocket demonstrated that several derivatives, particularly amb-14, amb-12, amb-11, amb-25, and amb-74, exhibited stronger binding affinities and favorable interaction profiles compared with the parent compound. Pharmacophore modeling using LigandScout confirmed the importance of hydrophobic contacts and hydrogen-bond interactions with critical residues, including Arg431 and Glu437. Furthermore, 200-ns molecular dynamics simulations revealed stable ligand–protein complexes with reduced flexibility in the armadillo repeat domain associated with transcriptional coactivator binding. MM-PBSA and MM-GBSA calculations supported the energetic stability of the selected complexes. ADMET prediction analysis indicated favorable pharmacokinetic properties, including high intestinal absorption, low blood–brain barrier permeability, minimal cytochrome P450 inhibition liability, and acceptable toxicity profiles, although potential hepatotoxicity requires further evaluation. Collectively, these findings suggest that benzoylated α-mangostin derivatives represent promising scaffolds for allosteric β-catenin inhibitors targeting Wnt/β-catenin-driven cancers.
No takes yet. Share an insight, caveat, or question.
Suryasaputra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: